Bethesda, Maryland-based Telcare, which offers an FDA cleared cellular-enabled glucose monitor and its cloud-based companion system, has scooped up $25.5 million in funding led by new backer Sequoia Capital with participation from its existing investor Qualcomm Life Fund. Telcare will use the funds to build out its marketing, sales, research and development. Telcare had previously raised about $4...
Last week German pharmaceutical company Boehringer Ingelheim announced a deal with Boston-based digital health company Healthrageous, which spun out of Partners Healthcare a few years ago. The companies plan to launch a pilot study to evaluate a lifestyle behavior modification program that aims to help people better manage type II diabetes.
The six-month study will leverage Healthrageous’...
Senior care company Independa has inked a deal with Telcare to add its cellular-enabled glucose meter to its remote management services for older people. Telcare's meter received clearance from the FDA last August, making it the first meter with cellular embedded.
The Telcare BGM device sends the glucose readings to the company's central server, which then sends it to Independa's cloud-based...
Boston-based Healthrageous has inked a co-marketing deal with Telcare, developer of the FDA-cleared cellular-enabled Telcare Blood Glucose Meter (BGM), to integrate blood glucose readings collected from the device into Healthrageous' "personal health improvement" platform. The companies plan to market the combined offering to health plans and self-insured employers.
Here's how the company...
A health plan that services self-funded employers in New York and New Jersey, MagnaCare, recently announced that it would offer Telcare's cellular-enabled blood glucose meter to its members. MagnaCare said the device and its corresponding apps will help its members be more proactive in managing their own health conditions, while also helping physicians stay better informed.
The deal with...
Walt Mossberg, technology columnist for the Wall Street Journal, broke the news this morning that Telcare's cellular-enabled blood glucose meter will become commercially available next week. (Assumedly timed to launch at CES, the big consumer tech event in Las Vegas.)
Mossberg, who has Type 2 diabetes, also gave the device an overall positive review with very few caveats.
Telcare BGM is a 3G-...
